Search - tctmd.com

Displaying 101 - 120 of 190

Sort: Relevancy | Date

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

Case #6: A Case of Failed TAVR ViV

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

Case #4: Bioprosthetic Valve Fracture - Before or After TAVR ViV?

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

Case #1: A Case of TAVR ViV Requiring an Advanced Approach

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

News Opinion Fellow Talk

Why I Chose a Career in Interventional Cardiology

Lowie Van Assche, MD

September 05, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir

June 21, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Presentation TCT 2017

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Presenter: John G. Webb

October 30, 2017

Presentation TCT 2017

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem

October 30, 2017

Advertisement

The Watch TAVR Trial: Rationale, Design and Status

Case #6: A Case of Failed TAVR ViV

Case #4: Bioprosthetic Valve Fracture - Before or After TAVR ViV?

Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV

Case #1: A Case of TAVR ViV Requiring an Advanced Approach

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Why I Chose a Career in Interventional Cardiology

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Next-Generation Large-Bore Closure Devices Arrive

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content